CEA protein antigen plus BCG Vaccine Mix for percutaneous use
IND 009549
Phase 1 mab active
Quick answer
CEA protein antigen plus BCG Vaccine Mix for percutaneous use for Rectal Cancer is a Phase 1 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Rectal Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active